Clinical trial
HKI-272 Ketoconazole Drug Interaction Study
NCT00380328 · Puma Biotechnology, Inc., Industry · Completed
Key facts
| NCT number | NCT00380328 |
|---|---|
| Title | HKI-272 Ketoconazole Drug Interaction Study |
| Official title | An Open-label, Randomized, 2-period Crossover, Drug Interaction Study to Evaluate the Potential Pharmacokinetic Interaction Between Multiple Doses of Ketoconazole and a Single Dose of HKI-272 Administered Orally to Healthy Subjects |
| Lead sponsor | Puma Biotechnology, Inc., Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | neratinib |
| Enrollment | 24 |
| Start date | Oct 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Sep 25, 2006 |
| Last update posted | May 14, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: